Visual Acuity
Conditions
Brief summary
This is a single-masked, 2×3 crossover, randomized-controlled, dispensing clinical trial to evaluate overall quality of vision.
Interventions
DEVICEJJVC Investigational Multifocal Contact Lenses
TEST
CONTROL
Sponsors
Johnson & Johnson Vision Care, Inc.
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* Potential subjects must satisfy all of the following criteria to be enrolled in the study 1. Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form. 2. Appear able and willing to adhere to the instructions set forth in this clinical protocol. 3. Be at least 40 years of age and not greater than 70 years of age at the time of consent. 4. Own a wearable pair of spectacles if required for their distance vision. 5. Be an adapted soft contact lens wearer in both eyes (i.e. worn lenses a minimum of 2 days per week for at least 6 hours per wear day, for 1 month or more duration). 6. Either already be wearing a presbyopic contact lens correction (e.g., reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or if not respond positively to at least one symptom on the Presbyopic Symptoms Questionnaire (Appendix D). 7. The subject's distance spherical equivalent refraction (vertex corrected if ≥-4.25 D) must be in the range of -1.25 D to -5.75 D or +0.75 D to +3.25 D in each eye. 8. The subject's refractive cylinder must be ≤0.75 D in each eye. 9. The subject's ADD power must be in the range of +0.75 D to +2.50 D. 10. The subject must have distance best corrected visual acuity of 20/20-3 or better in each eye.
Exclusion criteria
* Potential subjects who meet any of the following criteria will be excluded from participating in the study: The subject must not: 1. Be currently pregnant or lactating. 2. Have any active or ongoing ocular or systemic allergies that may interfere with contact lens wear. 3. Have any active or ongoing systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. This may include, but not be limited to, diabetes, hyperthyroidism, Sjögren's syndrome, xerophthalmia, acne rosacea, Stevens-Johnson syndrome, and immunosuppressive diseases or any infectious diseases (e.g. hepatitis, tuberculosis). 4. Have any previous, or planned, ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, lid procedures, dacryocystorhinostomy, peripheral iridotomy/iridectomy, cataract surgery, retinal surgery, etc.). 5. Have a history of amblyopia, strabismus or binocular vision abnormality. 6. Use of any of the following medications within 1 week prior to enrollment: oral retinoid, oral tetracyclines, anticholinergics, oral phenothiazines, oral/inhaled corticosteroids. See section 9.1 for further examples. 7. Use of any ocular medication, with the exception of rewetting drops. 8. Have a history of herpetic keratitis. 9. Have a history of irregular cornea. 10. Have a history of pathological dry eye. 11. Have Participated in any contact lens or lens care product clinical trial within 30 days prior to study enrollment. 12. Be an employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician). 13. Have any known hypersensitivity or allergic reaction to non-preserved rewetting drop solutions or sodium fluorescein. 14. Have clinically significant (Grade 2 or greater) corneal edema, corneal vascularization, corneal staining, tarsal abnormalities or bulbar injection, or any other corneal or ocular abnormalities which would contraindicate contact lens wear. 15. Have any current ocular infection or inflammation. 16. Have any current ocular abnormality that may interfere with contact lens wear.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clarity of Vision in Dim or Low Lighting | 1-Week Follow-up | Clarity of vision in dim or low lighting was assessed at the 1-week follow-up during each study period using the individual item: Clarity of vision in dim or low lighting conditions. This item used a 5-point like-rt scale of (1=Excellent, 2=Very good, 3=Good, 4=Fair and 5=Poor). Results were presented as the percentage of subjects' responses in each category by lens. For analysis and summary purposes three categories were used (T2B-Excellent and Very Good, Middle Box-Good and B2B-Fair and Poor). The 1-week follow-up from each study period (1, 2 and 3) were all included in the summary. |
| Clarity of Vision When Reading in Dim Light | 1-Week Follow-up | Clarity of vision when reading in dim light was assessed at the 1-week follow-up during each study period using the individual item: Clarity of vision when reading in dim light(e.g., menu or bill in a restaurant). This item used a 5-point like-rt scale of (1=Excellent, 2=Very good, 3=Good, 4=Fair and 5=Poor). Results were presented as the percentage of subjects' responses in each category by lens. For analysis and summary purposes three categories were used (T2B-Excellent and Very Good, Middle Box-Good and B2B-Fair and Poor). The 1-week follow-up from each study period (1, 2 and 3) were all included in the summary. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clarity of Distance Vision | 1-Week Follow-up | Clarity of Distance vision was assessed at the 1-week follow-up during each study period using the individual item: Clarity of distance vision (i.e., looking at things that are more than 5 feet away, such as street signs). This item used a 5-point like-rt scale of (1=Excellent, 2=Very good, 3=Good, 4=Fair and 5=Poor). Results were presented as the percentage of subjects' responses in each category by lens. For analysis and summary purposes three categories were used (T2B- Excellent and Very Good, Middle Box-Good and B2B- Fair and Poor). The 1-week follow-up from each study period (1, 2 and 3) were all included in the summary. |
| Clarity of Intermediate Vision | 1-Week Follow-up | Clarity of Intermediate vision was assessed at the 1-week follow-up during each study period using the individual item: Clarity of intermediate vision (i.e., looking at things 2-3 feet away, such as your computer screen). This item used a 5-point like-rt scale of (1=Excellent, 2=Very good, 3=Good, 4=Fair and 5=Poor). Results were presented as the percentage of subjects' responses in each category by lens. For analysis and summary purposes three categories were used (T2B-Excellent and Very Good, Middle Box-Good and B2B-Fair and Poor). The 1-week follow-up from each study period (1, 2 and 3) were all included in the summary. |
| Clarity of Near Vision | 1-Week Follow-up | Clarity of Near vision was assessed at the 1-week follow-up during each study period using the individual item: Clarity of intermediate vision (i.e., looking at things close up, such as reading a book). This item used a 5-point like-rt scale of (1=Excellent, 2=Very good, 3=Good, 4=Fair and 5=Poor). Results were presented as the percentage of subjects' responses in each category by lens. For analysis and summary purposes three categories were used (T2B-Excellent and Very Good, Middle Box-Good and B2B-Fair and Poor). The 1-week follow-up from each study period (1, 2 and 3) were all included in the summary. |
Countries
United States
Participant flow
Recruitment details
A total of 143 subjects were enrolled in this study. Of those enrolled, all 143 subjects were dispensed at least one study lens. Of those dispensed, 138 subjects completed the study while 5 subjects were discontinued.
Participants by arm
| Arm | Count |
|---|---|
| Hyperopes Subjects were classified as Hyperopic if the distance spherical equivalent refraction was in the range of +0.75 D to +3.25 D. | 56 |
| Myopes Subjects were classified as Myopic if the distance spherical equivalent refraction was in the range of -5.75 D to -1.25 D. | 87 |
| Total | 143 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Period 1 | Adverse Event | 0 | 1 |
| Period 1 | Protocol Deviation | 1 | 0 |
| Period 2 | Subject No Longer Meets Eligibility Criteria | 0 | 1 |
| Period 2 | Unsatisfactory Visual Response due to Test Article | 1 | 0 |
| Period 3 | Subject Was Not Returning for More Than A Week | 0 | 1 |
Baseline characteristics
| Characteristic | Myopes | Total | Hyperopes |
|---|---|---|---|
| Age, Continuous | 49.0 Years STANDARD_DEVIATION 5.84 | 52.3 Years STANDARD_DEVIATION 7.29 | 57.3 Years STANDARD_DEVIATION 6.41 |
| Race/Ethnicity, Customized Asian | 4 Participants | 6 Participants | 2 Participants |
| Race/Ethnicity, Customized Black or African American | 11 Participants | 12 Participants | 1 Participants |
| Race/Ethnicity, Customized Native Hawaiian or Other Pacific Islander | 0 Participants | 2 Participants | 2 Participants |
| Race/Ethnicity, Customized White | 72 Participants | 123 Participants | 51 Participants |
| Region of Enrollment United States | 87 Participants | 143 Participants | 56 Participants |
| Sex: Female, Male Female | 69 Participants | 114 Participants | 45 Participants |
| Sex: Female, Male Male | 18 Participants | 29 Participants | 11 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 142 | 0 / 142 |
| other Total, other adverse events | 0 / 142 | 0 / 142 |
| serious Total, serious adverse events | 0 / 142 | 0 / 142 |
Outcome results
Primary
Clarity of Vision in Dim or Low Lighting
Clarity of vision in dim or low lighting was assessed at the 1-week follow-up during each study period using the individual item: Clarity of vision in dim or low lighting conditions. This item used a 5-point like-rt scale of (1=Excellent, 2=Very good, 3=Good, 4=Fair and 5=Poor). Results were presented as the percentage of subjects' responses in each category by lens. For analysis and summary purposes three categories were used (T2B-Excellent and Very Good, Middle Box-Good and B2B-Fair and Poor). The 1-week follow-up from each study period (1, 2 and 3) were all included in the summary.
Time frame: 1-Week Follow-up
Population: All dispensed subjects regardless of deviation from protocol and completion status.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Senofilcon A C3 | Clarity of Vision in Dim or Low Lighting | Excellent or Very Good | 54.3 Percent |
| Senofilcon A C3 | Clarity of Vision in Dim or Low Lighting | Good | 33.3 Percent |
| Senofilcon A C3 | Clarity of Vision in Dim or Low Lighting | Fair or Poor | 12.4 Percent |
| Delefilcon A | Clarity of Vision in Dim or Low Lighting | Excellent or Very Good | 43.3 Percent |
| Delefilcon A | Clarity of Vision in Dim or Low Lighting | Good | 36.1 Percent |
| Delefilcon A | Clarity of Vision in Dim or Low Lighting | Fair or Poor | 20.6 Percent |
95% CI: [1.1, 2.46]Generalized Linear Mixed Model
Primary
Clarity of Vision When Reading in Dim Light
Clarity of vision when reading in dim light was assessed at the 1-week follow-up during each study period using the individual item: Clarity of vision when reading in dim light(e.g., menu or bill in a restaurant). This item used a 5-point like-rt scale of (1=Excellent, 2=Very good, 3=Good, 4=Fair and 5=Poor). Results were presented as the percentage of subjects' responses in each category by lens. For analysis and summary purposes three categories were used (T2B-Excellent and Very Good, Middle Box-Good and B2B-Fair and Poor). The 1-week follow-up from each study period (1, 2 and 3) were all included in the summary.
Time frame: 1-Week Follow-up
Population: All dispensed subjects regardless of deviation from protocol and completion status.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Senofilcon A C3 | Clarity of Vision When Reading in Dim Light | Excellent or Very Good | 46.2 Percent |
| Senofilcon A C3 | Clarity of Vision When Reading in Dim Light | Good | 32.4 Percent |
| Senofilcon A C3 | Clarity of Vision When Reading in Dim Light | Fair or Poor | 21.4 Percent |
| Delefilcon A | Clarity of Vision When Reading in Dim Light | Excellent or Very Good | 32.2 Percent |
| Delefilcon A | Clarity of Vision When Reading in Dim Light | Good | 34.1 Percent |
| Delefilcon A | Clarity of Vision When Reading in Dim Light | Fair or Poor | 33.6 Percent |
95% CI: [1.27, 2.79]Generalized Linear Mixed Model
Secondary
Clarity of Distance Vision
Clarity of Distance vision was assessed at the 1-week follow-up during each study period using the individual item: Clarity of distance vision (i.e., looking at things that are more than 5 feet away, such as street signs). This item used a 5-point like-rt scale of (1=Excellent, 2=Very good, 3=Good, 4=Fair and 5=Poor). Results were presented as the percentage of subjects' responses in each category by lens. For analysis and summary purposes three categories were used (T2B- Excellent and Very Good, Middle Box-Good and B2B- Fair and Poor). The 1-week follow-up from each study period (1, 2 and 3) were all included in the summary.
Time frame: 1-Week Follow-up
Population: All dispensed subjects regardless of deviation from protocol and completion status.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Senofilcon A C3 | Clarity of Distance Vision | Excellent or Very Good | 70.4 Percent |
| Senofilcon A C3 | Clarity of Distance Vision | Good | 21.9 Percent |
| Senofilcon A C3 | Clarity of Distance Vision | Fair or Poor | 7.7 Percent |
| Delefilcon A | Clarity of Distance Vision | Excellent or Very Good | 74.1 Percent |
| Delefilcon A | Clarity of Distance Vision | Good | 21.6 Percent |
| Delefilcon A | Clarity of Distance Vision | Fair or Poor | 4.3 Percent |
98.33% CI: [0.42, 1.3]Generalized Linear Mixed Model
Secondary
Clarity of Intermediate Vision
Clarity of Intermediate vision was assessed at the 1-week follow-up during each study period using the individual item: Clarity of intermediate vision (i.e., looking at things 2-3 feet away, such as your computer screen). This item used a 5-point like-rt scale of (1=Excellent, 2=Very good, 3=Good, 4=Fair and 5=Poor). Results were presented as the percentage of subjects' responses in each category by lens. For analysis and summary purposes three categories were used (T2B-Excellent and Very Good, Middle Box-Good and B2B-Fair and Poor). The 1-week follow-up from each study period (1, 2 and 3) were all included in the summary.
Time frame: 1-Week Follow-up
Population: All dispensed subjects regardless of deviation from protocol and completion status.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Senofilcon A C3 | Clarity of Intermediate Vision | Excellent or Very Good | 75.2 Percent |
| Senofilcon A C3 | Clarity of Intermediate Vision | Good | 21.0 Percent |
| Senofilcon A C3 | Clarity of Intermediate Vision | Fair or Poor | 3.8 Percent |
| Delefilcon A | Clarity of Intermediate Vision | Excellent or Very Good | 64.4 Percent |
| Delefilcon A | Clarity of Intermediate Vision | Good | 27.9 Percent |
| Delefilcon A | Clarity of Intermediate Vision | Fair or Poor | 7.7 Percent |
98.33% CI: [0.91, 2.75]Generalized Linear Mixed Model
Secondary
Clarity of Near Vision
Clarity of Near vision was assessed at the 1-week follow-up during each study period using the individual item: Clarity of intermediate vision (i.e., looking at things close up, such as reading a book). This item used a 5-point like-rt scale of (1=Excellent, 2=Very good, 3=Good, 4=Fair and 5=Poor). Results were presented as the percentage of subjects' responses in each category by lens. For analysis and summary purposes three categories were used (T2B-Excellent and Very Good, Middle Box-Good and B2B-Fair and Poor). The 1-week follow-up from each study period (1, 2 and 3) were all included in the summary.
Time frame: 1-Week Follow-up
Population: All dispensed subjects regardless of deviation from protocol and completion status.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Senofilcon A C3 | Clarity of Near Vision | Excellent or Very Good | 52.3 Percent |
| Senofilcon A C3 | Clarity of Near Vision | Good | 35.7 Percent |
| Senofilcon A C3 | Clarity of Near Vision | Fair or Poor | 12 Percent |
| Delefilcon A | Clarity of Near Vision | Excellent or Very Good | 38.0 Percent |
| Delefilcon A | Clarity of Near Vision | Good | 35.1 Percent |
| Delefilcon A | Clarity of Near Vision | Fair or Poor | 26.9 Percent |
98.33% CI: [1.24, 3.5]Generalized Linear Mixed Model